Home LiteratureArticle Details
PMID: 7933133 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element.

Journal of virology ·Vol. 68 ·No. 11 ·1994-11-00 ·Pages 7497-506

Meitinger C, Strobl LJ, Marschall G, Bornkamm GW, Zimber-Strobl U

Abstract

EBNA2 is one of the few genes of Epstein-Barr virus which are necessary for immortalization of human primary B lymphocytes. The EBNA2 protein acts as a transcriptional activator of several viral and cellular genes. For the TP1 promoter, we have shown previously that an EBNA2-responsive element (EBNA2RE) between -258 and -177 relative to the TP1 RNA start site is necessary and sufficient for EBNA2-mediated transactivation and that it binds EBNA2 through a cellular factor. To define the critical cis elements within this region, we cloned EBNA2RE mutants in front of the TP1 minimal promoter fused to the reporter gene for luciferase. Transactivation by EBNA2 was tested by transfection of these mutants in the absence and presence of an EBNA2 expression vector into the established B-cell line BL41-P3HR-1. The analysis revealed that two identical 11-bp motifs and the region 3' of the second 11-bp motif are essential for transactivation by EBNA2. Methylation interference experiments indicated that the same cellular factor in the absence of EBNA2 binds either one (complex I) or both (complex III) 11-bp motifs with different affinities, giving rise to two different specific protein-DNA complexes within the left-hand 54 bp of EBNA2RE. A third specific complex was shown previously to be present only in EBNA2-expressing cells and to contain EBNA2. Analysis of this EBNA2-containing complex revealed the same protection pattern as for complex III, indicating that EBNA2 interacts with DNA through binding of the cellular protein to the 11-bp motifs. Mobility shift assays with the different mutants demonstrated that one 11-bp motif is sufficient for binding the cellular factor, whereas for binding of EBNA2 as well as for efficient transactivation by EBNA2, both 11-bp motifs are required.

MeSH Terms
Animals Antigens, Viral/physiology Base Sequence Callithrix Carrier Proteins/metabolism Cell Line, Transformed DNA/metabolism DNA-Binding Proteins/physiology Deoxycholic Acid/pharmacology Epstein-Barr Virus Nuclear Antigens Genes, Viral Herpesvirus 4, Human/genetics Molecular Sequence Data Promoter Regions, Genetic Transcriptional Activation
Chemicals
Antigens, Viral Carrier Proteins DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Deoxycholic Acid DNA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Meitinger C
Institut für Klinische Molekularbiologie und Tumorgenetik im Forschungszentrum für Umwelt und Gesundheit, GSF, Munich, Germany.
Strobl L J
Marschall G
Bornkamm G W
Zimber-Strobl U
References (44)
44 references, click to expand
  1. Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas.
    Int J Cancer. 1979 Sep 15;24(3):294-302 PMID: 226484
  2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    J Virol. 1990 Mar;64(3):1002-13 PMID: 2154588
  3. Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region.
    J Virol. 1982 Sep;43(3):952-68 PMID: 6292473
  4. Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya.
    Int J Cancer. 1975 Jul 15;16(1):7-15 PMID: 170215
  5. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.
    J Mol Biol. 1976 Apr 15;102(3):511-30 PMID: 178878
  6. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  7. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
    J Virol. 1983 Oct;48(1):135-48 PMID: 6310141
  8. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  9. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6 PMID: 6209719
  10. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes.
    Virology. 1985 Mar;141(2):221-34 PMID: 3002016
  11. Gene regulation by proteins acting nearby and at a distance.
    Nature. 1986 Aug 21-27;322(6081):697-701 PMID: 3018583
  12. Geographical prevalence of two types of Epstein-Barr virus.
    Virology. 1986 Oct 15;154(1):56-66 PMID: 3019008
  13. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    J Virol. 1987 May;61(5):1310-7 PMID: 3033261
  14. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  15. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4 PMID: 2825176
  16. cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
    J Virol. 1990 Apr;64(4):1855-8 PMID: 2157069
  17. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    J Virol. 1990 May;64(5):2126-34 PMID: 2157875
  18. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    J Virol. 1990 Jun;64(6):2530-6 PMID: 2159528
  19. Acquired immunodeficiency syndrome-associated lymphomas.
    J Natl Cancer Inst Monogr. 1990;(10):45-54 PMID: 2189476
  20. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  21. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    J Virol. 1991 Jan;65(1):415-23 PMID: 1845900
  22. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients.
    Int J Cancer. 1991 Jan 21;47(2):188-92 PMID: 1846349
  23. Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein.
    Genes Dev. 1990 Dec;4(12B):2383-96 PMID: 1980658
  24. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    J Virol. 1991 May;65(5):2164-9 PMID: 1850003
  25. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3942-6 PMID: 1850841
  26. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    J Virol. 1991 Aug;65(8):4101-6 PMID: 1649318
  27. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    J Virol. 1991 Nov;65(11):5880-5 PMID: 1656076
  28. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    J Virol. 1991 Dec;65(12):6765-71 PMID: 1658373
  29. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    J Virol. 1992 May;66(5):2846-52 PMID: 1313905
  30. A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2.
    Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8030-4 PMID: 1325641
  31. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
    J Virol. 1992 Dec;66(12):7555-9 PMID: 1331538
  32. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    EMBO J. 1993 Jan;12(1):167-75 PMID: 8381349
  33. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
    Virus Res. 1993 Jan;27(1):55-69 PMID: 8383394
  34. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    J Virol. 1993 May;67(5):2853-61 PMID: 8386279
  35. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
  36. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    J Virol. 1994 Nov;68(11):6947-58 PMID: 7933076
  37. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.
    Cell. 1988 Apr 22;53(2):211-7 PMID: 3129195
  38. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease.
    Am J Clin Pathol. 1989 Jan;91(1):1-5 PMID: 2535912
  39. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    J Virol. 1989 Apr;63(4):1531-9 PMID: 2538644
  40. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    J Gen Virol. 1989 Jul;70 ( Pt 7):1755-64 PMID: 2544663
  41. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.
    Blood. 1989 Aug 1;74(2):810-6 PMID: 2546633
  42. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  43. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  44. Sequencing end-labeled DNA with base-specific chemical cleavages.
    Methods Enzymol. 1980;65(1):499-560 PMID: 6246368
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-11-00
Pages
7497-506
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237192
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]